Renaissance Technologies’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Renaissance Technologies’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-53,414	Closed	-$85K	–	4455
2023 Q1	$85K	Buy	53,414 +1,962	+4%	+$3.99K	﹤0.01%	3539
2022 Q4	$102K	Sell	51,452 -7,218	-12%	-$17.8K	﹤0.01%	3613
2022 Q3	$204K	Sell	58,670 -35,875	-38%	-$137K	﹤0.01%	3377
2022 Q2	$322K	Buy	94,545 +74,753	+378%	+$412K	﹤0.01%	3421
2022 Q1	$181K	Buy	+19,792	New	+$301K	﹤0.01%	3674
2021 Q3	–	Sell	-58,433	Closed	-$2.44M	–	4000
2021 Q2	$2.44M	Sell	58,433 -5,918	-9%	-$303K	﹤0.01%	2119
2021 Q1	$4.21M	Buy	64,351 +29,250	+83%	+$2.04M	0.01%	1754
2020 Q4	$2.31M	Sell	35,101 -1,903	-5%	-$124K	﹤0.01%	2044
2020 Q3	$2.01M	Buy	37,004 +11,145	+43%	+$853K	﹤0.01%	2128
2020 Q2	$2.47M	Sell	25,859 -8,424	-25%	-$628K	﹤0.01%	2073
2020 Q1	$1.76M	Sell	34,283 -10	-0%	-$1.04K	﹤0.01%	2117
2019 Q4	$2.82M	Sell	34,293 -4,493	-12%	-$315K	﹤0.01%	2161
2019 Q3	$3.32M	Sell	38,786 -8,806	-19%	-$940K	﹤0.01%	2023
2019 Q2	$6.07M	Sell	47,592 -273	-0.6%	-$39.3K	0.01%	1708
2019 Q1	$8.63M	Buy	47,865 +1,783	+4%	+$258K	0.01%	1463
2018 Q4	$5.12M	Sell	46,082 -8,166	-15%	-$1.06M	0.01%	1720
2018 Q3	$7.32M	Buy	54,248 +2,723	+5%	+$375K	0.01%	1557
2018 Q2	$7.11M	Buy	51,525 +1,578	+3%	+$217K	0.01%	1561
2018 Q1	$6.89M	Buy	49,947 +6,232	+14%	+$848K	0.01%	1608
2017 Q4	$5.38M	Buy	43,715 +2,930	+7%	+$402K	0.01%	1763
2017 Q3	$5.57M	Buy	40,785 +5,546	+16%	+$837K	0.01%	1707
2017 Q2	$6.18M	Buy	35,239 +9,942	+39%	+$1.41M	0.01%	1571
2017 Q1	$3.04M	Buy	25,297 +2,824	+13%	+$294K	﹤0.01%	2006
2016 Q4	$2.19M	Buy	22,473 +5,040	+29%	+$462K	﹤0.01%	2174
2016 Q3	$1.64M	Buy	17,433 +4,483	+35%	+$449K	﹤0.01%	2314
2016 Q2	$1.4M	Buy	12,950 +2,060	+19%	+$241K	﹤0.01%	2391
2016 Q1	$1.31M	Buy	10,890 +2,317	+27%	+$243K	﹤0.01%	2455
2015 Q4	$1.02M	Buy	8,573 +250	+3%	+$32.3K	﹤0.01%	2448
2015 Q3	$1.42M	Sell	8,323 -1,858	-18%	-$356K	﹤0.01%	2205
2015 Q2	$1.97M	Buy	10,181 +8,014	+370%	+$1.49M	﹤0.01%	2067
2015 Q1	$321K	Buy	2,167 +1,350	+165%	+$206K	﹤0.01%	2745
2014 Q4	$127K	Buy	817 +67	+9%	+$9.65K	﹤0.01%	2768
2014 Q3	$108K	Sell	750 -137	-15%	-$19.9K	﹤0.01%	2651
2014 Q2	$116K	Sell	887 -2,070	-70%	-$263K	﹤0.01%	2642
2014 Q1	$362K	Sell	2,957 -8,676	-75%	-$940K	﹤0.01%	2457
2013 Q4	$1.24M	Sell	11,633 -7,314	-39%	-$710K	﹤0.01%	1979
2013 Q3	$2.13M	Sell	18,947 -2,773	-13%	-$315K	0.01%	1633
2013 Q2	$2.45M	Buy	+21,720	New	+$2.66M	0.01%	1474

Other funds holding SRGA

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Renaissance Technologies's SRGA Position: Q2 2023 in Review

Renaissance Technologies sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 53,414 shares — an estimated $85K sold.

Renaissance Technologies first reported a position in SRGA in Q2 2013 and held it in 38 quarters. The position peaked at $8.63M in Q1 2019. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

Renaissance Technologies reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Renaissance Technologies sold 53,414 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $85K.
Renaissance Technologies first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
Renaissance Technologies's Surgalign Holdings, Inc. Common Stock position peaked at $8.63M in Q1 2019.
25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.